{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T21:16:35Z","timestamp":1761167795528,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone &amp; IGF Research"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ghir.2021.101378","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T21:10:56Z","timestamp":1610572256000},"page":"101378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Prevalence of thyroid cancer in patients with acromegaly and non-growth hormone secreting pituitary adenomas: A prospective cross-sectional study"],"prefix":"10.1016","volume":"56","author":[{"given":"Isadora Yasbick","family":"Spricido","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina Monteguti","family":"Feckinghaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00f4mulo Henrique Malaquias","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cleo Otaviano","family":"Mesa Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar Luiz","family":"Boguszewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ghir.2021.101378_bb0005","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1530\/EJE-16-0178","article-title":"Management of endocrine disease: acromegaly and cancer: an old debate revisited","volume":"175","author":"Boguszewski","year":"2016","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.ghir.2021.101378_bb0010","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1210\/er.2018-00166","article-title":"Growth Hormone\u2019s links to cancer","volume":"40","author":"Boguszewski","year":"2019","journal-title":"Endocr. Rev."},{"issue":"1","key":"10.1016\/j.ghir.2021.101378_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid."},{"issue":"2","key":"10.1016\/j.ghir.2021.101378_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088787","article-title":"Risk of thyroid nodular disease and thyroid cancer in patients with acromegaly--meta-analysis and systematic review","volume":"9","author":"Wolinski","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ghir.2021.101378_bb0025","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1210\/jc.2015-2372","article-title":"The incidence of cancer among acromegaly patients: results from the German acromegaly registry","volume":"100","author":"Petroff","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ghir.2021.101378_bb0030","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11102-016-0744-z","article-title":"Complications of acromegaly: thyroid and colon","volume":"20","author":"Tirosh","year":"2017","journal-title":"Pituitary."},{"key":"10.1016\/j.ghir.2021.101378_bb0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1055\/s-2005-870153","article-title":"Epigenetic mechanisms of tumorigenesis","volume":"37","author":"Farrell","year":"2005","journal-title":"Horm. Metab. Res."},{"issue":"1","key":"10.1016\/j.ghir.2021.101378_bb0040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1677\/ERC-06-0008","article-title":"Incidence and familial risks in pituitary adenoma and associated tumors","volume":"14","author":"Hemminki","year":"2007","journal-title":"Endocr. Relat. Cancer"},{"issue":"4","key":"10.1016\/j.ghir.2021.101378_bb0045","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2265.1998.00536.x","article-title":"Increased incidence of neoplasia in patients with pituitary adenomas. The Pituitary Study Group","volume":"49","author":"Popovic","year":"1998","journal-title":"Clin. Endocrinol."},{"issue":"7","key":"10.1016\/j.ghir.2021.101378_bb0050","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1210\/jc.2003-031601","article-title":"Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy","volume":"89","author":"Svensson","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.ghir.2021.101378_bb0055","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1530\/ERC-17-0253","article-title":"Acromegaly at diagnosis in 3173 patients from the Li\u00e8ge acromegaly survey (LAS) database","volume":"24","author":"Petrossians","year":"2017","journal-title":"Endocr. Relat. Cancer"},{"issue":"5","key":"10.1016\/j.ghir.2021.101378_bb0060","first-page":"395","article-title":"Acromegaly and cancer risk: a cohort study in Sweden and Denmark","volume":"13","author":"Baris","year":"2002","journal-title":"Cancer Causes Control"},{"issue":"5","key":"10.1016\/j.ghir.2021.101378_bb0065","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1055\/s-2004-817967","article-title":"Impact of disease activity on thyroid diseases in patients with acromegaly: basal evaluation and follow-up","volume":"112","author":"Herrmann","year":"2004","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"3","key":"10.1016\/j.ghir.2021.101378_bb0070","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s11102-010-0224-9","article-title":"Thyroid cancer is the most common cancer associated with acromegaly","volume":"13","author":"Gullu","year":"2010","journal-title":"Pituitary."},{"issue":"2","key":"10.1016\/j.ghir.2021.101378_bb0075","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1365-2265.2009.03619.x","article-title":"Increased cancer incidence in acromegaly: a nationwide survey","volume":"72","author":"Kauppinen-M\u00e4kelin","year":"2010","journal-title":"Clin. Endocrinol."},{"issue":"5","key":"10.1016\/j.ghir.2021.101378_bb0080","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1590\/S0004-27302012000500004","article-title":"Thyroid nodules in acromegaly","volume":"56","author":"Rogozinski","year":"2012","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.ghir.2021.101378_bb0085","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11102-012-0383-y","article-title":"Thyroid cancer in patients with acromegaly: a case-control study","volume":"16","author":"dos Santos","year":"2013","journal-title":"Pituitary."},{"issue":"9","key":"10.1016\/j.ghir.2021.101378_bb0090","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1590\/S0004-27302013000900003","article-title":"Prevalence of thyroid diseases in patients with acromegaly: experience of a Brazilian center","volume":"57","author":"Uchoa","year":"2013","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"issue":"8","key":"10.1016\/j.ghir.2021.101378_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104174","article-title":"Benign and malignant nodular thyroid disease in acromegaly. Is a routine thyroid ultrasound evaluation advisable?","volume":"9","author":"Reverter","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ghir.2021.101378_bb0100","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11102-013-0501-5","article-title":"Increased thyroid cancer risk in acromegaly","volume":"17","author":"Dagdelen","year":"2014","journal-title":"Pituitary."},{"issue":"4","key":"10.1016\/j.ghir.2021.101378_bb0105","first-page":"989","article-title":"High incidence of thyroid cancer among patients with acromegaly","volume":"21","author":"Kaldrymidis","year":"2016","journal-title":"J Buon."},{"issue":"9","key":"10.1016\/j.ghir.2021.101378_bb0110","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1530\/ERC-16-0553","article-title":"Acromegaly is associated with increased cancer risk: a survey in Italy","volume":"24","author":"Terzolo","year":"2017","journal-title":"Endocr. Relat. Cancer"},{"issue":"6","key":"10.1016\/j.ghir.2021.101378_bb0115","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1210\/jc.2017-02457","article-title":"Cancer incidence in patients with acromegaly: a cohort study and meta-analysis of the literature","volume":"103","author":"Dal","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ghir.2021.101378_bb0120","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5603\/EP.2017.0001","article-title":"Thyroid lesions in patients with acromegaly - case-control study and update to the meta-analysis","volume":"68","author":"Woli\u0144ski","year":"2017","journal-title":"Endokrynol. Pol."},{"issue":"8","key":"10.1016\/j.ghir.2021.101378_bb0125","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/1097-0142(19911015)68:8<1673::AID-CNCR2820680802>3.0.CO;2-0","article-title":"Acromegaly and gastrointestinal cancer","volume":"68","author":"Ron","year":"1991","journal-title":"Cancer."},{"issue":"8","key":"10.1016\/j.ghir.2021.101378_bb0130","first-page":"2730","article-title":"Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom acromegaly study group","volume":"83","author":"Orme","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.ghir.2021.101378_bb0135","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/BF03343997","article-title":"Liuzzi a; acromegaly study Group of the Italian Society of endocrinology. Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study","volume":"25","author":"Gasperi","year":"2002","journal-title":"J. Endocrinol. Investig."},{"issue":"4","key":"10.1016\/j.ghir.2021.101378_bb0140","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/eje.0.1510439","article-title":"Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish acromegaly registry (Registro Espanol de Acromegalia, REA)","volume":"151","author":"Mestron","year":"2004","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.ghir.2021.101378_bb0145","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4158\/EP-2019-0254","article-title":"No benefit of dedicated thyroid nodule screening in patients with acromegaly","volume":"26","author":"Lai","year":"2020","journal-title":"Endocr. Pract."},{"issue":"1","key":"10.1016\/j.ghir.2021.101378_bb0150","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/1097-0142(195701\/02)10:1<100::AID-CNCR2820100113>3.0.CO;2-V","article-title":"Occurrence of cancer in acromegaly and in hypopituitarism","volume":"10","author":"Mustacchi","year":"1957","journal-title":"Cancer."},{"issue":"1","key":"10.1016\/j.ghir.2021.101378_bb0155","first-page":"55","article-title":"Ascertainment and natural history of treated acromegaly in Northern Ireland","volume":"59","author":"Ritchie","year":"1990","journal-title":"Ulster Med. J."},{"issue":"3","key":"10.1016\/j.ghir.2021.101378_bb0160","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1365-2265.1997.2561053.x","article-title":"Increased incidence of neoplasia in females with acromegaly","volume":"47","author":"Cheung","year":"1997","journal-title":"Clin. Endocrinol."},{"issue":"4","key":"10.1016\/j.ghir.2021.101378_bb0165","doi-asserted-by":"crossref","first-page":"D1","DOI":"10.1530\/EJE-19-1009","article-title":"Thyroid and colorectal cancer screening in acromegaly patients: should it be different from that in the general population?","volume":"183","author":"Terzolo","year":"2020","journal-title":"Eur. J. Endocrinol."},{"issue":"10","key":"10.1016\/j.ghir.2021.101378_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110241","article-title":"Tumorigenesis of papillary thyroid cancer is not BRAF-dependent in patients with acromegaly","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ghir.2021.101378_bb0175","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1055\/a-0915-1982","article-title":"Disease activity may not affect the prognosis of coexisting thyroid cancer in acromegalic patients","volume":"128","author":"Gul","year":"2020","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"7","key":"10.1016\/j.ghir.2021.101378_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101560","article-title":"AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-up","volume":"9","author":"Mian","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ghir.2021.101378_bb0185","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1530\/EJE-07-0013","article-title":"Mortality and GH deficiency: a nationwide study","volume":"157","author":"Stochholm","year":"2007","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.ghir.2021.101378_bb0190","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.beem.2017.02.004","article-title":"Controversies in the risk of neoplasia in GH deficiency","volume":"31","author":"Pekic","year":"2017","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.ghir.2021.101378_bb0195","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Wass JA; Endocrine Society. Acromegaly: an endocrine society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.ghir.2021.101378_bb0200","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz096","article-title":"A consensus on the diagnosis and treatment of acromegaly comorbidities: an update","volume":"105","author":"Giustina","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Growth Hormone &amp; IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637421000010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637421000010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:52:07Z","timestamp":1761087127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637421000010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":40,"alternative-id":["S1096637421000010"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2021.101378","relation":{},"ISSN":["1096-6374"],"issn-type":[{"type":"print","value":"1096-6374"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of thyroid cancer in patients with acromegaly and non-growth hormone secreting pituitary adenomas: A prospective cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2021.101378","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101378"}}